Cumberland Pharmaceuticals (CPIX) EPS (Diluted) Growth (1y) (2011 - 2026)
Cumberland Pharmaceuticals (CPIX) EPS (Diluted) Growth (1y) (2011 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EPS (Diluted) Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 44.07 Bn | 43.10 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 43.41 Bn | 39.75 Bn | 2.15 Bn | -304.28% |
| 3 | Zoetis | 31.83 Bn | 30.15 Bn | 1.05 Bn | 1.28% |
| 4 | Takeda Pharmaceutical | 28.77 Bn | 22.97 Bn | 5.10 Bn | -15.70% |
| 5 | United Therapeutics | 22.27 Bn | 19.61 Bn | 683.80 Mn | 13.47% |
| 6 | Viatris | 18.76 Bn | 17.87 Bn | 1.46 Bn | -2,504.14% |
| 7 | Neurocrine Biosciences | 15.65 Bn | 15.26 Bn | 935.80 Mn | 30.20% |
| 8 | Elanco Animal Health | 11.93 Bn | 11.40 Bn | 798.00 Mn | 385.28% |
| 9 | Dr Reddys Laboratories | 10.16 Bn | 10.00 Bn | - | - |
| 10 | Cumberland Pharmaceuticals | 116.48 Mn | 112.62 Mn | - | -480.58% |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -151.64% |
| Mar 31, 2026 | -356.68% |
| Dec 31, 2025 | 29.55% |
| Sep 30, 2025 | -19.13% |
| Jun 30, 2025 | 37.08% |
| Mar 31, 2025 | 160.61% |
| Dec 31, 2024 | 69.31% |
| Sep 30, 2024 | -46.87% |
| Jun 30, 2024 | -231.84% |
| Mar 31, 2024 | -1,242.62% |
| Dec 31, 2021 | -41.29% |
| Sep 30, 2021 | -35.05% |
| Jun 30, 2021 | -31.88% |
| Mar 31, 2021 | -38.13% |
| Dec 31, 2020 | -63.06% |
| Sep 30, 2020 | -41.46% |
| Jun 30, 2020 | -2.52% |
| Mar 31, 2020 | -29.15% |
| Dec 31, 2019 | 140.39% |
| Sep 30, 2019 | 182.17% |